Interpace Biosciences Inc (IDXG)

OTC Markets
Currency in USD
1.2300
-0.0200(-1.60%)
Closed
IDXG Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
1.23001.2500
52 wk Range
0.51953.5400
Key Statistics
Edit
Prev. Close
1.25
Open
1.25
Day's Range
1.23-1.25
52 wk Range
0.5195-3.54
Volume
2.1K
Average Volume (3m)
17.57K
1-Year Change
19.05%
Book Value / Share
-13.11
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IDXG Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
  • Interpace Biosciences Misses Q2 EPS by 41c
    • Investing.com
Show more

Interpace Biosciences Inc Company Profile

Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test for the diagnosis and prognosis of pancreatic cancer; PanDNA, a molecular only version of PancraGEN; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company primarily serves physicians, cancer center, clinics, laboratories, pathology groups, and hospitals. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.

Compare IDXG to Peers and Sector

Metrics to compare
IDXG
Peers
Sector
Relationship
P/E Ratio
1.1x−3.5x−0.6x
PEG Ratio
0.000.150.00
Price/Book
−0.1x1.2x2.6x
Price / LTM Sales
0.1x1.7x3.1x
Upside (Analyst Target)
-50.5%51.7%
Fair Value Upside
Unlock13.8%7.5%Unlock

Earnings

Latest Release
Nov 04, 2024
EPS / Forecast
0.31 / --
Revenue / Forecast
12.30M / --
EPS Revisions
Last 90 days

FAQ

What Is the Interpace Biosciences (IDXG) Stock Price Today?

The Interpace Biosciences stock price today is 1.23

What Stock Exchange Does Interpace Biosciences Trade On?

Interpace Biosciences is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Interpace Biosciences?

The stock symbol for Interpace Biosciences is "IDXG."

What Is the Interpace Biosciences Market Cap?

As of today, Interpace Biosciences market cap is 5.50M.

What is Interpace Biosciences Earnings Per Share?

The Interpace Biosciences EPS is 1.08.

What Is the Next Interpace Biosciences Earnings Date?

Interpace Biosciences will release its next earnings report on Mar 25, 2025.

From a Technical Analysis Perspective, Is IDXG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.